Probiotic supplementation can positively affect anxiety and depressive symptoms: A systematic review of randomized controlled trials

In this 2016 systematic review, the databases Medline, PsycINFO, PubMed, Scopus, and Web of Science were searched for randomized controlled trials (published between January 1990 and January 2016) that investigated the effect of probiotic supplementation on depression and anxiety symptoms. Little support was found for the therapeutic use of probiotics in depression and anxiety from the ten trials included in this review (4 clinically diagnosed, 6 non-clinical). But the findings imply humans may benefit psychologically from these probiotics, despite the inconsistencies in methodologies between the included studies. Future studies are imperative now to add to the current knowledge on probiotics and its developmental, modulatory, and metagenomic impacts on the GI microbiota. [NPID: probiotics, gut-brain axis, gut microbiota, gut bacteria, microbiota, gut microbiome, stress, prebiotics, depression, anxiety, GI microbiota]

Year: 2016

Reference: Pirbaglou, M., Katz, J., de Souza, R. J., Stearns, J. C., Motamed, M., & Ritvo, P. (2016). Probiotic supplementation can positively affect anxiety and depressive symptoms: a systematic review of randomized controlled trials. Nutrition research (New York, N.Y.), 36(9), 889–898. https://doi.org/10.1016/j.nutres.2016.06.009

Related Studies

Consumption of fermented milk product with probiotic modulates brain activity

In mice, changes in the gut microbiota have been shown to affect visceral nociceptive reflexes, emotional behavior, and signaling processes. However, it has not been demonstrated that altering the gut microbiota with antibiotics or probiotics causes these changes in people. Tillisch et al. (2013) examined whether healthy women who consumed a probiotic-fortified fermented milk product […]

Adjunctive probiotic microorganisms to prevent rehospitalization in patients with acute mania: A randomized controlled trial

This 2018 trial explored the potential of probiotic organism consumption in the prevention of psychiatric rehospitalizations among 66 patients recently discharged for mania. The probiotic administered to the patients contained Lactobacillus rhamnosus strain GG and Bifidobacterium animalis subsp. lactis strain Bb12. The subjects were randomly assigned to either receive the dose of probiotics or treatment […]